According to TherapeuticsMD's latest financial reports the company's total assets are $50.49 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $90.45 M | -46.62% |
2021-12-31 | $0.16 B | -6.68% |
2020-12-31 | $0.18 B | -31.72% |
2019-12-31 | $0.26 B | 25.47% |
2018-12-31 | $0.21 B | 48% |
2017-12-31 | $0.14 B | 0.53% |
2016-12-31 | $0.14 B | 93.24% |
2015-12-31 | $73.72 M | 24.8% |
2014-12-31 | $59.07 M | -4.74% |
2013-12-31 | $62.01 M | 946.53% |
2012-12-31 | $5.92 M | 311.89% |
2011-12-31 | $1.43 M | 20.17% |
2010-12-31 | $1.19 M | 40.89% |
2009-12-31 | $0.84 M | 1461.52% |
2008-12-31 | $0.05 M | -89.01% |
2007-12-31 | $0.49 M | -73.47% |
2006-12-31 | $1.86 M | 3.3% |
2005-12-31 | $1.8 M | 66.05% |
2004-12-31 | $1.08 M | 21.19% |
2003-12-31 | $0.89 M | 19.25% |
2002-12-31 | $0.75 M | 8.36% |
2001-12-31 | $0.69 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 448,479.01% | ๐บ๐ธ USA |
AbbVie ABBV | $134.71 B | 266,691.44% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | $10.88 M | -78.43% | ๐บ๐ธ USA |
Royalty Pharma RPRX | $16.38 B | 32,343.90% | ๐ฌ๐ง UK |
Lannett Company LCI | $0.33 B | 562.71% | ๐บ๐ธ USA |